Purchase Order 75N90025P00659

Award Date 8/25/25
Potential Completion Date 8/24/26
Potential Value $28K
Federal Agency
NIH Clinical Center
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Psomagen Inc., a for-profit organization and manufacturer, is for $48,825 to provide GENOTYPING SERVICES (DNA QC/MICROARRAY) to the National Institute on Aging, a civilian federal agency. The contract is a firm fixed-price purchase order with a performance period ending on January 6, 2026. Psomagen Inc. is a subsidiary of Macrogen, Inc. and operates CLIA-certified and CAP-accredited facilities to support research and clinical applications. This contract is not...
This is a firm fixed-price purchase order awarded by the National Institute of Mental Health (NIMH), a civilian agency, to Psomagen Inc., a genomics and molecular biology services company based in Rockville, Maryland. The $180,000 contract has a period of performance ending on May 19, 2025. Psomagen Inc. is a subsidiary of the parent company Macrogen, Inc., which is a leading provider of genomic sequencing and bioinformatics services to the U.S. federal government. The contract does not have a...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $30,000 firm fixed-price purchase order was not set aside for any specific business type. Under this contract, Psomagen will provide a range of genomic and molecular biology services to support research across various NIH institutes, including the National Institute on Aging,...
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $11,381 firm-fixed-price purchase order contract was awarded on July 5, 2011, with a completion date of July 4, 2012. The contract did not have a set-aside designation. Psomagen Inc. is a multiomics contract laboratory that provides a range of genomic and molecular biology services,...
This federal contract award, with a ceiling value of $27,600, was issued by the National Institute of Mental Health (NIMHD) to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for bioinformatics services related to RNA/DNA sequencing. Psomagen, a small business, has a history of providing genomic services to various federal agencies, including the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and Smithsonian Institution, through both contract and...
This federal contract award is for $313,500.00 in single cell multiome sequencing services, provided by Psomagen Inc., a subsidiary of Macrogen, Inc. The contract was awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH). The contract is a firm fixed price purchase order with a period of performance through March 1, 2026. Psomagen Inc. is a prime contractor that specializes in delivering a wide range of genomic and molecular biology...
This is a federal contract award to Psomagen Inc., a subsidiary of Macrogen, Inc., by the National Institute of Allergy and Infectious Diseases (NIAID) to provide other functions for a total ceiling value of $6,000.00. The contract is a firm-fixed price purchase order with an ultimate completion date of October 23, 2013. Psomagen is a multiomics contract laboratory service and data analysis provider that specializes in delivering a wide range of genomic and molecular biology services to...
This firm-fixed-price purchase order was awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the National Institutes of Health (NIH), to Psomagen Inc., a for-profit organization and manufacturer of goods. The $23,030 contract is for OLINK HT ANALYSIS services, which likely refers to genomic sequencing and analysis capabilities provided by Psomagen. The contract has an ultimate completion date of July 29, 2025 and was awarded on July 30, 2024...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $10,000.00 firm fixed-price purchase order is for DNA sequencing services. The contract has no set-aside designation. Psomagen Inc. is a provider of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, that supports...
This federal contract award was issued by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $4,250 firm fixed-price purchase order was for unspecified genomic and molecular biology services to support research initiatives at NHGRI. Psomagen Inc. has established itself as a key provider of advanced sequencing and omics capabilities to federal agencies, having been awarded numerous...

This federal contract award is for LAB TESTING SERVICES provided by Psomagen Inc., a for-profit genomics and molecular biology services company based in Rockville, Maryland. The $27,597 firm fixed-price purchase order was awarded on August 25, 2025 by the National Institutes of Health (NIH) Clinical Center, a civilian agency, with a completion date of August 24, 2026. The contract does not have a set-aside designation.

Psomagen is a subsidiary of Macrogen, Inc. and has provided a wide range of genomic services to multiple federal agencies, including the NIH, USDA, and FDA, through various contract vehicles. This includes work on research areas such as neurodegenerative diseases, sickle cell disease, infectious diseases, and precision medicine initiatives. Psomagen also holds two significant federal Indefinite Delivery Vehicle (IDV) contracts, including a $500 million contract with the National Heart, Lung and Blood Institute to support the Trans-Omics for Precision Medicine (TOPMed) initiative.

Generated 8/23/25, 9:51 AM